Long-Term Debt - Rollforward (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Nov. 19, 2020 |
Dec. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Debt Instrument [Line Items] | ||||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | ||
| Beginning Balance | $ 80,053,526 | $ 55,136,089 | $ 80,046,101 | $ 55,136,089 | $ 55,136,089 | $ 55,136,089 | $ 16,516,598 | |||||
| Issued | 25,000,000 | 40,180,000 | ||||||||||
| Principal Payments | (7,425) | (46,101) | (82,563) | (1,560,509) | ||||||||
| Ending Balance | $ 80,046,101 | 80,046,101 | $ 80,000,000 | 80,000,000 | 80,053,526 | 80,046,101 | 55,136,089 | $ 16,516,598 | ||||
| LTD-C | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Beginning Balance | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | |||||
| Issued | $ 15,000,000.0 | |||||||||||
| Ending Balance | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | $ 15,000,000 | ||||
| LTD-D | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Beginning Balance | 65,000,000 | 40,000,000 | 65,000,000 | 40,000,000 | 40,000,000 | 40,000,000 | ||||||
| Issued | 61,058,281 | 25,000,000 | 61,058,281 | 40,000,000 | ||||||||
| Ending Balance | 65,000,000 | 65,000,000 | $ 65,000,000 | 65,000,000 | 65,000,000 | 65,000,000 | 40,000,000 | |||||
| LTD-E | ||||||||||||
| Debt Instrument [Line Items] | ||||||||||||
| Beginning Balance | 53,526 | $ 136,089 | 46,101 | $ 136,089 | 136,089 | 136,089 | ||||||
| Issued | 180,000 | |||||||||||
| Principal Payments | (7,425) | $ (46,101) | (82,563) | (43,911) | ||||||||
| Ending Balance | $ 46,101 | $ 46,101 | $ 53,526 | $ 46,101 | $ 136,089 | |||||||
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|